Last reviewed · How we verify
NCT04961255
Effects of Post-COVID-19 on Quadriceps Femoral Muscle-tendon Unit
trial in Post-COVID-19 in 90 participants. Status unknown.
30 August 2024
Quick facts
| Lead sponsor | University of Brasilia |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 24 August 2021 |
| Primary completion | 30 August 2024 |
| Estimated completion | 30 December 2024 |
| Sites | 1 location across Brazil |
Conditions studied
- Post-COVID-19 — all drugs for Post-COVID-19 →
- Healthy Participants — all drugs for Healthy Participants →
Sponsor
University of Brasilia
Who can join
Adults 18 to 80, any sex, with Post-COVID-19 or Healthy Participants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The physiological/biomechanical characteristics related to muscle and tendon architecture and their possible relationship with the loss of muscle strength and fatigue in patients who were infected with COVID-19 are totally unknown. The aim of this study is to evaluate inflammatory markers, the isometric maximum voluntary force of the knee extensor torque, muscle fatigue, neuromuscular adaptations, muscle architecture, tendinous properties of quadriceps components, oxygen extraction, and body composition in participants after diagnosis with Covid-19 who had moderate and severe levels of involvement compared to a healthy control group.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Intra- and Inter-Rater Reliability and Agreement of Ultrasound Imaging of Muscle Architecture and Patellar Tendon in Post-COVID-19 Patients Who Had Experienced Moderate or Severe COVID-19 Infection.
de Jesus Ferreira LG, de Almeida Ventura Á, da Silva Almeida I, Mansur H, et al · · 2022 · cited 5× · PMID 36498509 · DOI 10.3390/jcm11236934 -
Fatigue and neuromuscular function in long COVID: A one-year follow-up study.
Almeida IDS, Ferreira LGJ, Vaz MA, Cipriano Junior G, et al · · 2025 · cited 1× · PMID 40991619 · DOI 10.1371/journal.pone.0332242 -
Impact of COVID-19 on patellar tendon properties over the first year after infection.
de Jesus Ferreira LG, da Silva Almeida I, Costa RR, Roriz GV, et al · · 2026 · PMID 41501086 · DOI 10.1038/s41598-025-06879-w -
Persistent neuromuscular disorders associated with changes in tibialis anterior and gastrocnemius lateralis muscle architecture in long-covid: an observational longitudinal study.
da Silva Almeida I, de Jesus Ferreira LG, Cipriano G, Costa RR, et al · · 2025 · PMID 41038893 · DOI 10.1038/s41598-025-17126-7 -
Long COVID-19 alters muscle architecture and muscle-tendon force transmission: a one-year longitudinal study.
Ferreira LGJ, da Silva Almeida I, Costa RR, Roriz GV, et al · · 2025 · PMID 40926885 · DOI 10.3389/fphys.2025.1641046
Verify or expand the search:
- PubMed search for NCT04961255
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Brasilia trials
Trials by the same sponsor.
- NCT07453485 — Immediate Effects of Neuromuscular Electrical Stimulation on Pain and Function in Achilles Tendon Disorders · NA · recruiting
- NCT07515989 — Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnos · NA · recruiting
- NCT06651099 — Trial-based Economic Evaluation of a Mobile Health Intervention for Individuals With Chronic Non-specific Low Back Pain · NA · recruiting
- NCT06318728 — Musculotendinous Adaptations in High and Low- Performance Triathletes · unknown
- NCT06266845 — Efficacy of Gamification With Escape-Room for Arrhythmia Identification in Critical Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04961255 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Brasilia
- Last refreshed: 5 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04961255.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing